GRACE THERAPEUTICS INC (GRCE) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:GRCE • US00439U1043

3.68 USD
-0.03 (-0.81%)
Last: Feb 4, 2026, 08:24 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
GRCE revenue by date.GRCE revenue by date.
200K
-100.00%
9.384M45.9M
389.13%
101.53M
121.20%
142.15M
40.01%
182.76M
28.57%
214.04M
17.12%
EBITDA
YoY % growth
GRCE ebitda by date.GRCE ebitda by date.
-31.34M
-136.17%
-22.12M
29.42%
-9.8M
55.70%
N/A
-56.53%
N/A
-18.19%
-14.37M
37.36%
-17.034M
-50.00%
-14.994M
11.98%
-12.546M
16.33%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
GRCE ebit by date.GRCE ebit by date.
-33.67M
-119.35%
-24.44M
27.41%
-10.72M
56.14%
-13.543M
-43.10%
-15.228M
-18.97%
-12.342M
37.72%
-17.823M
-56.80%
-15.912M
10.72%
-17.34M
-8.97%
-14.708M
15.18%
63.966M
534.90%
98.69M
54.29%
133.41M
35.18%
158.8M
19.03%
Operating Margin
GRCE operating margin by date.GRCE operating margin by date.
N/AN/A-5,360.00%N/AN/AN/AN/AN/A-184.78%-32.04%63.00%69.43%73.00%74.19%
EPS
YoY % growth
GRCE eps by date.GRCE eps by date.
-41.82
-0.99%
N/A
47.07%
N/A-0.67-1.98
-194.20%
-1.47
57.12%
-1.22
10.47%
-1.02
-34.15%
-0.76
25.50%
0.51
167.11%
1.62
218.58%
2.44
50.00%
2.54
4.16%
2.96
16.45%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.29
-9.85%
-0.36
-457.00%
-0.26
-21.43%
-0.23
-291.00%
-0.20
28.57%
-0.15
57.14%
Revenue
Q2Q % growth
918K1.326M2.652M3.57M
EBITDA
Q2Q % growth
-4.59M
-24.09%
-5.61M
-76.64%
-5.304M
-71.76%
-3.672M
-45.31%
-2.652M
42.22%
-918K
83.64%
EBIT
Q2Q % growth
-4.59M
-23.92%
-5.61M
-76.25%
-5.304M
-71.65%
-4.794M
-89.56%
-4.08M
11.11%
-3.162M
43.64%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2026
Q2Q % growth
-0.06
81.81%
-0.190.1368.20%
Q1 2026
Q2Q % growth
-0.21
22.36%
-0.220.016.42%
Q4 2025
Q2Q % growth
0.10
155.47%
-0.320.42131.63%
Q3 2025
Q2Q % growth
-0.26
-18.36%
-0.440.1840.72%
Q2 2025
Q2Q % growth
-0.33
-73.63%
-0.460.1328.43%
Q1 2025
Q2Q % growth
-0.27
-120.98%
-0.26-0.02-6.07%
Q4 2024
Q2Q % growth
-0.18
93.75%
-0.360.1849.50%
Q3 2024
Q2Q % growth
-0.22
44.80%
-0.230.016.37%
Q2 2024
Q2Q % growth
-0.19 -0.11-0.08-69.34%
Q4 2023
Q2Q % growth
-2.88
-361.43%
-0.63-2.25-357.73%
Q3 2023
Q2Q % growth
-0.40
26.03%
-0.690.2942.18%
Q3 2022
Q2Q % growth
-0.54
73.33%
-0.38-0.16-42.20%
Q3 2021
Q2Q % growth

57.43%
-2.02%
Q2 2021
Q2Q % growth
-0.47
96.21%
-2.602.1382.00%
Q1 2021
Q2Q % growth
-2.39
55.60%
-2.840.4515.77%
Q4 2020
Q2Q % growth
8.65 -4.0512.69313.68%
Q2 2020
Q2Q % growth
-12.36 -4.27-8.10-189.83%
Q1 2020
Q2Q % growth
-5.38 -6.290.9114.41%
GRCE Yearly EPS VS EstimatesGRCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30 -40
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth

-100.00%
%
Q3 2022
Q2Q % growth

-100.00%
%
Q1 2020
Q2Q % growth
96.074K-96.074K-100.00%
GRCE Yearly Revenue VS EstimatesGRCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -51.35% 0% 0%
RevenueN/A N/A N/A N/A